Treatment of Patients With Chronic Hepatitis B With Hepatitis B Immunoglobulins
Stopped A full recruitment for the study was no longer expected.
Conditions
Interventions
- DRUG: Human hepatitis B Immunoglobulin (Hepatect®CP/Zutectra®)
Sponsor
Hannover Medical School
Collaborators